The Cicor Group, a leading provider of advanced electronics manufacturing services, announced strong financial results for the third quarter of 2024.
Revenue increased by 26.3% to CHF 120.4 million, bringing the year-to-date total to CHF 351.7 million. The company's strong order intake, with a book-to-bill ratio of 1.01, indicates a healthy pipeline of future business.
Despite a decline in the European EMS market, Cicor has successfully gained market share and strengthened its position as a leading partner for complex electronics in its core markets of medical technology, industrial, and aerospace & defense.
Looking ahead, Cicor remains optimistic about its growth prospects for the remainder of 2024. The company expects sales to reach between CHF 470-510 million and EBITDA to reach CHF 50-60 million, provided there are no significant changes in geopolitical, economic, and financial conditions.